China Universal Asset Management »

Eupraxia Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $72k 10k 7.24

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Ishares Gold Trust Etp (IAU)
Spdr Gold Shares Etp (GLD)
Spdr Gold Minishares Trust Etp (GLDM)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)

View all positions for China Universal Asset Management

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Ameriprise Financial
Woodline Partners
Seven Fleet Capital Management

View all funds holding Eupraxia Pharmaceuticals